Keywords: Canada, Ontario Institute for Cancer Resarch, Diagnostic tools, Immunotherapy

Canada’s OICR makes equity investments in novel cancer therapies and diagnostic tools

Article | 28 April 2010

The Ontario Institute for Cancer Research (OICR) in Canada has made unspecified equity investments in three Ontario technologies to accelerate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in